Edwards Lifesciences Performance

Edwards Lifesciences Corporation -- USA Stock  

USD 111.66  0.46  0.41%

Macroaxis gives Edwards Lifesciences performance score of 0 on a scale of 0 to 100. The firm shows Beta (market volatility) of 0.5208 which denotes to the fact that as returns on market increase, Edwards Lifesciences returns are expected to increase less than the market. However during bear market, the loss on holding Edwards Lifesciences will be expected to be smaller as well.. Even though it is essential to pay attention to Edwards Lifesciences historical returns, it is always good to be careful when utilizing equity current trending patternss. Macroaxis philosophy towards predicting future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Edwards Lifesciences Corporation exposes twenty-eight different technical indicators which can help you to evaluate its performance. Edwards Lifesciences has expected return of -0.0044%. Please be advised to confirm Edwards Lifesciences Potential Upside as well as the relationship between Kurtosis and Day Typical Price to decide if Edwards Lifesciences past performance will be repeated at some point in the near future.
Investment Horizon     30 Days    Login   to change

Relative Risk vs. Return Landscape

If you would invest  11,128  in Edwards Lifesciences Corporation on September 19, 2017 and sell it today you would lose (22)  from holding Edwards Lifesciences Corporation or give up 0.2% of portfolio value over 30 days. Edwards Lifesciences Corporation is generating negative expected returns and assumes 0.9359% volatility on return distribution over the 30 days horizon. Put differently, 8% of equity instruments are less risky than the company on the bases of their historical return distribution and some 99% of equities are expected to be superior in generating returns on investments over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Allowing for the 30-days total investment horizon, Edwards Lifesciences Corporation is expected to under-perform the market. In addition to that, the company is 4.06 times more volatile than its market benchmark. It trades about 0.0 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.55 per unit of volatility.

Operating Margin

Edwards Lifesciences Operating Margin
Based on recorded statements Edwards Lifesciences Corporation has Operating Margin of 29.95%. This is 191.06% lower than that of the Healthcare sector, and significantly higher than that of Healthcare Products industry, The Operating Margin for all stocks is 374.52% lower than the firm.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.

Edwards Lifesciences Daily Price Distribution

The median price of Edwards Lifesciences for the period between Tue, Sep 19, 2017 and Thu, Oct 19, 2017 is 110.22 with a coefficient of variation of 0.94. The daily time series for the period is distributed with a sample standard deviation of 1.03, arithmetic mean of 110.13, and mean deviation of 0.79. The Stock received some media coverage during the period.
0 

Risk-Adjusted Performance

Over the last 30 days Edwards Lifesciences Corporation has generated negative risk-adjusted returns adding no value to investors with long positions.

One Month Efficiency

Edwards Lifesciences Sharpe Ratio = -0.0047
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsEW

Estimated Market Risk

 0.94
  actual daily
 
 92 %
of total potential
  

Expected Return

 0.0
  actual daily
 
 1 %
of total potential
  

Risk-Adjusted Return

 0.0
  actual daily
 
 1 %
of total potential
  
Based on monthly moving average Edwards Lifesciences is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding it to a well-diversified portfolio.